LSDI

8-K - Lucy Scientific Discovery, Inc. (0001865127) (Filer)

8-K - Lucy Scientific Discovery, Inc. (0001865127) (Filer)

Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide, announces that it has a hearing scheduled for June 25, 2024 before a Nasdaq Hearings Panel (the "Panel") regarding its plan to regain compliance with Nasdaq Listing Rule 5550(b) (the "Stockholders' Equity Rule").

Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide, announces that it has a hearing scheduled for June 25, 2024 before a Nasdaq Hearings Panel (the "Panel") regarding its plan to regain compliance with Nasdaq Listing Rule 5550(b) (the "Stockholders' Equity Rule"). On May 21, 2024, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") that, per Nasdaq Listing Rule 5250(c)(1) (the "Filings Rule"), the Company is delinquent in filing its Quarterly Report on Form 1

Gainers Sharps Technology (NASDAQ:STSS) shares rose 50.5% to $0.32 during Friday's after-market session. The market value of their outstanding shares is at $5.0 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares increased by 9.75% to $2.25. The market value of their outstanding shares is at $3.2 million. Lucy Scientific Discovery (NASDAQ:LSDI) stock moved upwards by 6.89% to $0.93. The market value of their outstanding shares is at $1.6 million. Adial Pharmaceuticals (NASDAQ:ADIL) shares increased by 6.4% to $1.33. The company's market cap stands at $5.6 million. Aclaris Therapeutics (NASDAQ:ACRS) shares rose 5.4% to $1.17. The market value of their outstanding shares is at $83.3 mi

Gainers GT Biopharma (NASDAQ:GTBP) shares rose 173.5% to $8.53 during Monday's regular session. The market value of their outstanding shares is at $11.7 million. As per the press release, Q1 earnings came out 3 days ago. NovaBay Pharmaceuticals (AMEX:NBY) shares rose 78.07% to $0.21. The company's market cap stands at $7.9 million. NKGen Biotech (NASDAQ:NKGN) stock moved upwards by 48.66% to $1.67. The market value of their outstanding shares is at $37.4 million. Scorpius Holdings (AMEX:SCPX) shares rose 36.98% to $0.14. The market value of their outstanding shares is at $5.1 million. Scilex Holding (NASDAQ:SCLX) stock moved upwards by 32.22% to $1.19. The market value of their outstand

Shares of Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) fell sharply during Friday's session after the company reduced its dividend and said it expects third-quarter and fourth-quarter results below its prior expectations. Cracker Barrel Old Country Store shares dipped 14.4% to $49.01 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers Fangdd Network Group Ltd. (NASDAQ:DUO) shares jumped 258.6% to $1.4709. FangDD filed 2023 annual report on Form 20-F. Akanda Corp. (NASDAQ:AKAN) jumped 129.4% to $0.3053 after jumping around 27% on Thursday. Crown ElectroKinetics Corp (NASDAQ:CRKN) shares jumped 89.6% to $0.4580. The stock has seen interes

Gainers Akanda (NASDAQ:AKAN) shares increased by 103.8% to $0.27 during Friday's regular session. The company's market cap stands at $8.6 million. NovaBay Pharmaceuticals (AMEX:NBY) shares rose 48.66% to $0.18. The company's market cap stands at $6.7 million. Pasithea Therapeutics (NASDAQ:KTTA) stock increased by 29.77% to $8.63. The company's market cap stands at $8.9 million. As per the news, the Q1 earnings report came out 3 days ago. TransCode Therapeutics (NASDAQ:RNAZ) stock moved upwards by 27.23% to $1.13. The market value of their outstanding shares is at $6.8 million. Onconetix (NASDAQ:ONCO) stock increased by 26.73% to $0.18. The market value of their outstanding shares is at

Shares of Doximity, Inc. (NYSE:DOCS) rose sharply in today's pre-market trading reported stronger-than-expected financial results for the fourth quarter on Thursday. Doximity's fourth-quarter revenue increased 6% year-over-year to $118.1 million, which beat the consensus estimate of $116.4 million, according to Benzinga Pro. The company reported adjusted earnings of 25 cents per share, beating analyst estimates of 20 cents per share. The company said it expects first-quarter revenue to be between $119.5 million and $120.5 million versus estimates of $119.23 million. Doximity shares jumped 13.7% to $27.00 in the pre-market trading session. Here are some other stocks moving in pre-

Gainers Akanda (NASDAQ:AKAN) shares rose 177.7% to $0.37 during Friday's pre-market session. The company's market cap stands at $11.7 million. Scorpius Holdings (AMEX:SCPX) stock increased by 28.17% to $0.13. The market value of their outstanding shares is at $4.6 million. NovaBay Pharmaceuticals (AMEX:NBY) shares moved upwards by 27.0% to $0.15. The market value of their outstanding shares is at $5.7 million. ZimVie (NASDAQ:ZIMV) shares moved upwards by 23.61% to $20.99. The company's market cap stands at $572.7 million. Kintara Therapeutics (NASDAQ:KTRA) stock moved upwards by 17.16% to $0.17. The market value of their outstanding shares is at $6.6 million. As per the press release, Q

Gainers Scorpius Holdings (AMEX:SCPX) shares rose 20.9% to $0.12 during Thursday's after-market session. The market value of their outstanding shares is at $4.3 million. Kintara Therapeutics (NASDAQ:KTRA) stock increased by 19.22% to $0.17. The company's market cap stands at $6.7 million. The company's, Q3 earnings came out 2 days ago. Doximity (NYSE:DOCS) stock rose 11.4% to $26.45. The market value of their outstanding shares is at $4.9 billion. As per the news, the Q4 earnings report came out today. MEI Pharma (NASDAQ:MEIP) stock increased by 10.92% to $3.25. The company's market cap stands at $21.6 million. Akso Health Group (NASDAQ:AHG) stock increased by 9.36% to $0.69. The compan

Shares of Fluent Inc (NASDAQ:FLNT) fell sharply during Thursday's session after posting weaker-than-expected quarterly results. Fluent posted adjusted loss of 30 cents per share, versus market expectations for a loss of 10 cents per share. The company's quarterly sales came in at $65.983 million missing estimates of $66.433 million, according to data from Benzinga Pro. Fluent shares dipped 12.6% to $3.47 on Thursday. Here are some other stocks moving in today’s mid-day session. Gainers Lucy Scientific Discovery Inc. (NASDAQ:LSDI) shares jumped 239% to $1.75. Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) jumped 100% to $0.1196 after jumping around 34% on Wednesday.

Gainers Lucy Scientific Discovery (NASDAQ:LSDI) shares moved upwards by 205.8% to $1.56 during Thursday's regular session. The company's market cap stands at $2.7 million. SINTX Techs (NASDAQ:SINT) shares moved upwards by 31.66% to $0.17. The company's market cap stands at $20.6 million. As per the news, the Q1 earnings report came out 3 days ago. Nanoviricides (AMEX:NNVC) stock increased by 23.56% to $2.22. The market value of their outstanding shares is at $26.1 million. The company's, Q3 earnings came out yesterday. Scorpius Holdings (AMEX:SCPX) shares moved upwards by 23.35% to $0.1. The company's market cap stands at $3.4 million. Onconetix (NASDAQ:ONCO) stock moved upwards by 23.2

U.S. stocks traded slightly higher this morning on Thursday. Following the market opening Thursday, the Dow traded up 0.01% to 39,913.23 while the NASDAQ rose 0.06% to 16,753.07. The S&P 500 also rose, gaining, 0.06% to 5,311.26. Check This Out: Oklo Is ‘Too Risky,’ Jim Cramer Says: Buy This General Electric Spinoff Instead Leading and Lagging SectorsConsumer staples shares rose by 1.1% on Thursday. In trading on Thursday, materials shares fell by 0.4%. Top Headline U.S. initial jobless claims declined by 10,000 to 222,000 in the week ending May 11, compared to market estimates of 220,000. Equities Trading UP                        Lucy Scientific Discovery Inc. (NA

Gainers Lucy Scientific Discovery (NASDAQ:LSDI) stock moved upwards by 123.5% to $1.14 during Thursday's pre-market session. The market value of their outstanding shares is at $2.0 million. SINTX Techs (NASDAQ:SINT) stock moved upwards by 19.67% to $0.15. The market value of their outstanding shares is at $18.7 million. As per the press release, Q1 earnings came out 3 days ago. Dynatronics (NASDAQ:DYNT) stock increased by 16.7% to $0.51. The market value of their outstanding shares is at $2.7 million. Ontrak (NASDAQ:OTRK) shares moved upwards by 15.99% to $0.31. The company's market cap stands at $14.8 million. The company's, Q1 earnings came out 2 days ago. NovaBay Pharmaceuticals (AME

NT 10-Q - Lucy Scientific Discovery, Inc. (0001865127) (Filer)

Gainers SINTX Techs (NASDAQ:SINT) shares increased by 22.2% to $0.16 during Wednesday's after-market session. The company's market cap stands at $19.1 million. As per the news, the Q1 earnings report came out 2 days ago. Petros Pharma (NASDAQ:PTPI) shares rose 12.85% to $0.58. The market value of their outstanding shares is at $4.0 million. Bluejay Diagnostics (NASDAQ:BJDX) shares increased by 10.22% to $0.58. The market value of their outstanding shares is at $1.5 million. INVO Bioscience (NASDAQ:INVO) stock rose 7.47% to $1.15. The market value of their outstanding shares is at $4.3 million. Scorpius Holdings (AMEX:SCPX) shares moved upwards by 7.2% to $0.08. The market value of their

8-K - Lucy Scientific Discovery, Inc. (0001865127) (Filer)

Gainers Akanda (NASDAQ:AKAN) shares moved upwards by 69.1% to $0.16 during Wednesday's pre-market session. The company's market cap stands at $1.8 million. NanoVibronix (NASDAQ:NAOV) shares moved upwards by 25.17% to $0.92. The market value of their outstanding shares is at $2.5 million. Predictive Oncology (NASDAQ:POAI) shares increased by 23.4% to $1.74. The market value of their outstanding shares is at $7.0 million. Lucy Scientific Discovery (NASDAQ:LSDI) shares moved upwards by 19.0% to $0.99. The company's market cap stands at $1.7 million. Emergent BioSolutions (NYSE:EBS) stock moved upwards by 18.08% to $2.22. The company's market cap stands at $116.3 million. As per the press r

8-K - Lucy Scientific Discovery, Inc. (0001865127) (Filer)

DEA Revisits Proposed Ban On Two Psychedelic Compounds: Researchers Disagree, Insist On Hearings The Drug Enforcement Administration (DEA) is revisiting its stance on the classification of two psychedelic compounds, 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC).   The agency has proposed both be listed as Schedule I substances under the Controlled Substances Act (CSA). If added to the Schedule I list, these compounds would be officially considered as having high abuse potential with no recognized medical use. The evaluation is being disputed by experts. Three formal requests for a hearing were submitted, prompting a reconsideration by the agency.

Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression Partners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have jointly announced positive initial results from a Phase 2a study of Beckley’s novel formulation of 5-MeO-DMT in Treatment Resistant Depression (TRD.)  BPL-003 is a synthetic and patent-protected benzoate salt formulation of 5-MeO-DMT (aka mebufotenin) designed for intranasal administration. The open-label study assessed safety, tolerability and efficacy of the compound at a single 10mg dose, alongside psychological support, in patients with moderate-to-severe TRD (who withdrew from concomitant antidepressants.) Learn more. Utah Hospita

FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement Clinical-stage psychedelics biopharma company Cybin Inc. (NYSE:CYBN) announced that the Food and Drug Administration has granted Breakthrough Therapy designation to CYB003, its proprietary deuterated psilocybin analog targeting the adjunctive treatment of Major Depressive Disorder (MDD.)  It makes the group of psychedelic-based treatments for mental health conditions that have in recent years received such status granted by the U.S. federal agency five therapies total: Cybin's, MindMed's (NASDAQ:MNMD) LSD-derived treatment for